New drug helped patients lose 28% of body weight: Eli Lilly
CTV News
—
Eli Lilly said on Thursday that its experimental drug retatrutide helped patients diagnosed with obesity lose more than 28 per cent of their weight over a year and a half in a key trial that helps pave the way for the firm to seek regulatory approval and launch the drug next year.
Lilly weight loss drug results
- A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time —
- New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner —
- Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight - Reuters Reuters —
- New weight-loss shot appears to outperform other obesity drugs on market The Guardian —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —